Accumulated OCI

$48.50M

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX Accumulated OCI

Latest reported$48.50Mperiod endingJun 30, 2026

VRTX Quarterly Accumulated OCI ($0.00 → $48.50M)

Quarterly accumulated oci

High-resolution chart · PNG

VRTX accumulated oci history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Accumulated OCI — Quarterly (USD)
Period ending	Accumulated OCI (USD)
Jun 30, 2026	48,500,000
Mar 31, 2026	24,800,000
Dec 31, 2025	-15,900,000
Sep 30, 2025	-64,500,000
Jun 30, 2025	-101,100,000
Mar 31, 2025	68,100,000
Dec 31, 2024	127,800,000
Sep 30, 2024	28,800,000
Jun 30, 2024	22,500,000
Mar 31, 2024	17,300,000
Dec 31, 2023	-14,300,000
Sep 30, 2023	-3,000,000
Jun 30, 2023	-39,800,000
Mar 31, 2023	-13,100,000
Dec 31, 2022	800,000
Sep 30, 2022	97,600,000
Jun 30, 2022	57,500,000
Mar 31, 2022	11,300,000
Dec 31, 2021	15,900,000
Sep 30, 2021	11,537,000
Jun 30, 2021	-25,159,000
Mar 31, 2021	-33,302,000
Dec 31, 2020	-68,480,000
Sep 30, 2020	-40,982,000
Jun 30, 2020	-14,121,000
Mar 31, 2020	13,383,000
Dec 31, 2019	-1,973,000
Sep 30, 2019	18,847,000
Jun 30, 2019	-3,201,000
Mar 31, 2019	6,000,000
Dec 31, 2018	659,000
Sep 30, 2018	307,000
Jun 30, 2018	-4,605,000
Mar 31, 2018	-39,743,000
Dec 31, 2017	-11,572,000
Sep 30, 2017	-25,129,000
Jun 30, 2017	-21,753,000
Mar 31, 2017	16,025,000
Dec 31, 2016	21,173,000
Sep 30, 2016	-3,845,000
Jun 30, 2016	-3,390,000
Mar 31, 2016	-4,899,000
Dec 31, 2015	1,824,000
Sep 30, 2015	1,511,000
Jun 30, 2015	-1,707,000
Mar 31, 2015	791,000
Dec 31, 2014	917,000
Sep 30, 2014	1,161,000
Jun 30, 2014	-23,000
Mar 31, 2014	-297,000
Dec 31, 2013	-306,000
Sep 30, 2013	-550,000
Jun 30, 2013	-1,230,000
Mar 31, 2013	-1,149,000
Dec 31, 2012	-550,000
Sep 30, 2012	-416,000
Jun 30, 2012	-673,000
Mar 31, 2012	-628,000
Dec 31, 2011	-1,053,000
Sep 30, 2011	-945,000
Jun 30, 2011	-707,000
Mar 31, 2011	-633,000
Dec 31, 2010	-1,067,000
Sep 30, 2010	-677,000
Jun 30, 2010	-558,000
Mar 31, 2010	-1,080,000
Dec 31, 2009	-640,000
Sep 30, 2009	-115,000
Jun 30, 2009	418,000
Mar 31, 2009	1,143,000
Dec 31, 2008	3,168,000
Sep 30, 2008	675,000
Jun 30, 2008	647,000
Mar 31, 2008	1,993,000
Dec 31, 2007	881,000
Sep 30, 2007	309,000
Jun 30, 2007	-595,000
Mar 31, 2007	-506,000
Dec 31, 2006	-962,000
Sep 30, 2006	-1,245,000
Jun 30, 2006	8,252,000
Mar 31, 2006	10,895,000
Dec 31, 2005	-16,281,000
Sep 30, 2005	-17,398,000
Jun 30, 2005	-14,901,000
Mar 31, 2005	-16,947,000
Dec 31, 2004	-13,031,000
Sep 30, 2004	-11,293,000
Jun 30, 2004	-12,330,000
Mar 31, 2004	808,000
Dec 31, 2003	1,578,000
Sep 30, 2003	3,683,000
Jun 30, 2003	4,684,000
Mar 31, 2003	4,435,000
Dec 31, 2002	6,764,000
Sep 30, 2002	7,894,000
Jun 30, 2002	6,654,000
Mar 31, 2002	4,932,000
Dec 31, 2001	11,114,000
Sep 30, 2001	12,293,000